9999999997-15-013462.txt : 20150917 9999999997-15-013462.hdr.sgml : 20150917 20150917121414 ACCESSION NUMBER: 9999999997-15-013462 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150917 DATE AS OF CHANGE: 20150917 20150917 20150917 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REGENXBIO Inc. CENTRAL INDEX KEY: 0001590877 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1933 Act SEC FILE NUMBER: 333-206430 FILM NUMBER: 151111739 BUSINESS ADDRESS: STREET 1: 9712 MEDICAL CENTER DRIVE STREET 2: SUITE 100 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-552-8181 MAIL ADDRESS: STREET 1: 9712 MEDICAL CENTER DRIVE STREET 2: SUITE 100 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: REGENXBIO, Inc. DATE OF NAME CHANGE: 20150116 FORMER COMPANY: FORMER CONFORMED NAME: ReGenX Biosciences, LLC DATE OF NAME CHANGE: 20131101 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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